TrialHeadache2020

Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study.

Richard B Lipton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.